Recent studies have indicated that endoglin can inhibit NO and heme oxygenase-1 (HO-1) synthesis and reduce production of CO and bilirubin, thereby leading to endothelial dysfunction, blood pressure elevation and development of severe preeclampsia [24–26]. The gene discussed is HMOX1; the disease is preeclampsia.